Clinical Implications

  • Shi-Ming Tu
Part of the Cancer Treatment and Research book series (CTAR, volume 154)


Not knowing the relationship between stem cells and cancer cells, we may unwittingly expose ourselves to some lurking danger.


Stem Cell Cancer Stem Cell Normal Stem Cell Epithelioid Sarcoma Progenitor Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMedGoogle Scholar
  2. 2.
    Huff CA, Matsui W, Smith BD et al (2006) The paradox of response and survival in cancer therapeutics. Blood 107:431–434CrossRefPubMedGoogle Scholar
  3. 3.
    Bach PB, Jett JR, Pastorino U et al (2007) Computed tomography screening and lung cancer outcomes. JAMA 297:953–961, Erratum in JAMA 2007;298(5):518CrossRefPubMedGoogle Scholar
  4. 4.
    Arber DA, Tamayo R, Weiss LM (1998) Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 29:498–504CrossRefPubMedGoogle Scholar
  5. 5.
    Strohmeyer T, Reese D, Press M et al (1995) Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511–515CrossRefPubMedGoogle Scholar
  6. 6.
    Natkunam Y, Rouse RV, Zhu S et al (2000) Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am J Pathol 156:21–27PubMedGoogle Scholar
  7. 7.
    Leaf C (2004) Why we’re losing the war on cancer (and how to win it) (Avastin, Erbitux, Gleevec...the new wonder drugs might make you think we’re finally beating this dreaded scourge. We’re not. Here’s how to turn the fight around.) Fortune Magazine, March 22, 2004, pp 77–92Google Scholar
  8. 8.
    Hong WK, Endicott J, Itri LM et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505CrossRefPubMedGoogle Scholar
  9. 9.
    Steinbach G, Lynch PM, Phillips RK et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952CrossRefPubMedGoogle Scholar
  10. 10.
    Thompson IM, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224CrossRefPubMedGoogle Scholar
  11. 11.
    Tabar V, Tomishima M, Panagiotakos G et al (2008) Therapeutic cloning in individual parkinsonian mice. Nat Med 14:379–381CrossRefPubMedGoogle Scholar
  12. 12.
    Pucéat M, Ballis A (2007) Embryonic stem cells: from bench to bedside. Clin Pharmacol Ther 82:337–339CrossRefPubMedGoogle Scholar
  13. 13.
    Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations